Pharma Two B to Present Additional Positive Results from
Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed...
United States Dan Teleman American Academy Of Neurology Pharma Twob Ltd Drug Administration Movement Disorders
Source: globenewswire.com